Comparison Chart Summit Therapeutics Inc.

Stocks

SMMT

US86627T1088

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-07 EDT			After hours 20:00:00
15.88 ^USD	-0.31%		21.43	+34.95%

06-22	Analyst recommendations: Accenture, Conocophillips, Diamondback Energy, Oracle, Applied Materials…
06-12	Summit Therapeutics Insider Bought Shares Worth $49,987,200, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SUMMIT THERAPEUTICS INC.	Bio Therapeutic Drugs	-0.31%	+8.99%	-9.21%	-29.77%	+114.30%	12.33B